" class="no-js "lang="en-US"> ADNP Kids Research Foundation - Medtech Alert
Thursday, September 18, 2025
ADNP Kids Research Foundation | Pharmtech Focus

ADNP Kids Research Foundation

About ADNP Kids Research Foundation

ADNP Kids Research Foundation

WHO WE ARE
The ADNP Kids Research Foundation is the worlds first non-profit organization to fund research, publish papers and promote awareness for ADNP Syndrome. We are a strong international patient focused organization with the largest collection of diagnosed patients worldwide, approximately 300.

OUR MISSION
To advance the awareness and understanding of ADNP Syndrome / Helsmoortel – Van Der Aa Syndrome (ADNP) by supporting research for treatments and drug development, increasing awareness and scientific understanding, promoting individualized specialty care and protocol, supporting families and providing information to help all individuals with ADNP realize their full potential and have a better quality of life.

ADNP SYNDROME
ADNP Syndrome (also known as Helsmoortel-VanDerAa Syndrome / HVDAS) is an extremely rare neurodevelopmental genetic disorder caused by a mutation or partial deletion in the ADNP (Activity Dependent Neuroprotective Protein) gene.

ADNP Syndrome can cause problems with the neurological, cardiovascular, endocrine, immune, musculoskeletal and gastrointestinal systems, as well as vision, hearing, growth, feeding and sleep. Developmentally, it can cause mild to severe delays in intelligence, speech and global motor planning, (including gross motor, fine motor and oral motor). It causes behavior disorders such as Autism Spectrum Disorder (ASD) in a substantial proportion of cases. In fact, it is estimated: ADNP to be mutated in at least 0.17% of genetic autism cases, making it one of the most frequent ASD-associated genes known to date.

Related Story

Rarebase Launches a Neuroscience Drug Discovery Platform Collaborating with 15 Rare Disease Patient Organizations

September 15 2021

Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function’s […]